Pseudogout, also known as calcium pyrophosphate dihydrate (CPPD) crystal deposition disease, is a rare form of arthritis that affects about 1 in 100,000 people. It is a form of joint inflammation that can be quite painful and disabling. It is important for doctors to understand the causes of this disorder so that they can provide the best possible treatment for their patients.
Pseudogout is an inflammatory form of arthritis that is caused by the deposition of calcium pyrophosphate dihydrate (CPPD) crystals in the joints. The crystals form in the joint and cause the body’s immune system to respond, leading to inflammation and pain. The most common joints affected are the knees, wrists, and shoulders, but other joints can also be affected. Symptoms of pseudogout include sudden, severe pain, swelling, and stiffness in the affected joint, as well as redness and warmth in the area.
The exact cause of pseudogout is unknown, but there are several factors that may increase the risk of developing the condition. Age is a major risk factor, as pseudogout is more common in people over the age of 60. Certain medical conditions, such as kidney disease, thyroid disease, and metabolic disorders, can also increase the risk of pseudogout. Other risk factors include certain medications, such as diuretics, and certain genetic disorders, such as hyperparathyroidism.
Pseudogout is typically diagnosed through a physical exam and imaging tests. During the physical exam, the doctor will look for signs of inflammation and pain in the affected joint. Imaging tests, such as X-rays and MRI, can help to confirm the diagnosis. The doctor may also order a blood test to look for levels of CPPD crystals in the blood. In some cases, a sample of joint fluid may be taken and examined under a microscope for the presence of CPPD crystals.
The treatment of pseudogout depends on the severity of the symptoms. The main goals of treatment are to reduce pain and inflammation and to prevent further damage to the joint. Nonsteroidal anti-inflammatory drugs (NSAIDs) are often prescribed to reduce pain and inflammation. Corticosteroids may also be used to reduce inflammation. In some cases, surgery may be necessary to remove the CPPD crystals or to repair damaged joints.
There is no sure way to prevent pseudogout, but there are some steps that can be taken to reduce the risk. These include avoiding medications that can increase the risk of pseudogout, maintaining a healthy weight, and exercising regularly. It is also important to get regular medical checkups, as early diagnosis and treatment can help to reduce the severity of the condition.
Pseudogout is a rare form of arthritis that can be quite painful and disabling. While the exact cause of the condition is unknown, there are several factors that may increase the risk of developing it. Diagnosis is typically done through a physical exam and imaging tests, and treatment typically involves medications to reduce pain and inflammation. While there is no sure way to prevent pseudogout, there are some steps that can be taken to reduce the risk. It is important for doctors to understand the causes and treatments of pseudogout so that they can provide the best possible care for their patients.
1.
Certain surgical gestures during prostate removal linked to better sexual function recovery
2.
There has been a recent decrease in the risk of a recurrence of colorectal cancer in stage I to III cases.
3.
In patients with advanced lung cancer, cemiplimab combined with chemotherapy extends life and enhances quality of life.
4.
An "exploding" field of antibody-drug conjugates is making progress against ovarian cancer.
5.
Black women have a higher risk of dying from all types of breast cancer, meta-analysis reveals
1.
Trends in Incidence, Care, and Surgery for Medullary Thyroid Cancer: A Review
2.
Surgery for Tracheoesophageal Fistula: What to Expect Before, During, and After
3.
What Is A Normal Fibrinogen Level, And How Can It Affect Your Health
4.
Breakthroughs in Cancer Care: From Rare Diagnoses to Advanced and Early-Stage Treatments
5.
ERASur: Evaluating Total Ablative Therapy in Limited Metastatic Colorectal Cancer
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
2.
What Therapy Would Yield the Best Outcomes In Patients with R/R B-cell ALL?
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part VI
4.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
5.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part VIII
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation